ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 619677 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 619677; 2) Community: the network communities that were significantly associated with the response to NSC 619677; 3) Molecule: the relationships between components within communities and NSC 619677; 4) MDR: the compounds that were significantly associated with the NSC 619677.

NSC Compound Enrichment Correlation
NSC 624358 Tricyclo[4.4.0.0(2,7)]decane-5-one, 4,4-dibromo-2-methyl- 0.0115521552688257 0.69278859
NSC 629749 .beta.-Lapachone 0.0115521552688257 0.39639317
NSC 633497 Null 0.0115521552688257 0.45685939
NSC 634761 Cis-dibromocarbonylacetonitrile-bis-(triphenylphosphine) osmium(II) 0.0115521552688257 0.36361529
NSC 648365 Insulin-Methotrexate conjugate 0.0115521552688257 0.46576922
NSC 652175 2-Pyrazolin-5-one, 1-[(2-hydroxyphenyl)carbonyl]- 3-methyl-4-[(4-nitrophenyl)methylene]- 0.0115521552688257 0.017380513
NSC 656576 Midostaurin 0.0115521552688257 -0.04831568
NSC 664558 Null 0.0115521552688257 -0.036896139
NSC 676916 1-[m-methyl anilino malonyl]-3-methyl-4-[4'-.beta.-sulphato ethyl sulphonyl phenyl azo]-5-pyrazolone 0.0115521552688257 0.40603488
NSC 678989 Uracil, 1-[1,2-bis(ethoxycarbonyl)ethenyl]-, cis- 0.0115521552688257 0.53299655
Total:129  Current:54    [First] [Prev] [Next] [Last]